Literature DB >> 83192

Effects of isoprinosine, levamisole, muramyl dipeptide, and SM1213 on lymphocyte and macrophage function in vitro.

J W Hadden.   

Abstract

Four immunopotentiators, levamisole, isoprinosine, muramyl dipeptide, and SM1213, were analyzed in vitro for their effect on phytohemagglutinin-induced lymphocyte proliferation and lymphokine-induced macrophage proliferation and activation to kill Listeria monocytogenes. Isoprinosine augmented all three functions. Levamisole augmented lymphocyte proliferation and lymphokine-induced macrophage activation. Muramyl dipeptide and SM1213 induced macrophage activation directly. The effects of these agents on these cells at concentrations relevant to in vivo therapy support their immunopharmacologic application to modify cellular immunity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 83192

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  5 in total

1.  Pharmacokinetics of the immunomodulatory 1,2-O-isopropylidene-3-O-3'-(N',N'-dimethyl-amino-n-propyl)-D-glucofuranose hydrochloride in normal human volunteers.

Authors:  E R Garrett; A Van Peer; P Altmayer; W Schuermann; P Lücker
Journal:  J Pharmacokinet Biopharm       Date:  1982-06

2.  Inhibition of psoriatic cell proliferation in in vitro skin models by amiprilose hydrochloride.

Authors:  M L Chapman; S D Dimitrijevich; J C Hevelone; D Goetz; J Cohen; G E Wise; R W Gracy
Journal:  In Vitro Cell Dev Biol       Date:  1990-10

3.  Stimulation of migration of human monocytes by bacterial cell walls and muramyl peptides.

Authors:  T Ogawa; S Kotani; K Fukuda; Y Tsukamoto; M Mori; S Kusumoto; T Shiba
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

4.  Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice.

Authors:  J Leibovici; Y Stark; M Wolman
Journal:  Br J Exp Pathol       Date:  1983-06

5.  Immunomodulation by isoprinosine: effects on in vitro immune functions of lymphocytes from humans with autoimmune diseases.

Authors:  T Nakamura; N Miyasaka; R M Pope; N Talal; I J Russell
Journal:  Clin Exp Immunol       Date:  1983-04       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.